Apogee Therapeutics, Inc. · NASDAQ:APGE

Henderson Jane sold 2,000 Apogee Therapeutics, Inc. shares (Form 4)

Traded Apr 1, 2026 · Filed Apr 3, 2026

On Apr 1, 2026, Henderson Jane (Chief Financial Officer) sold 2,000 Apogee Therapeutics, Inc. shares at an average US$85.01 for US$170K under a trading plan, leaving 177,371 shares. Filed Apr 3, 2026 (Form 4).

Sold
2,000 shares
Price
US$85.01 average (US$84.46 to US$85.46)
Value
US$170K
Holding after
177,371 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Common StockSale900US$84.46178,471Direct
Apr 1, 2026Common StockSale1,100US$85.46177,371Direct

Source

View original at SEC

Related